Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.27B
-
Number of holders
-
2208
-
Total 13F shares, excl. options
-
989M
-
Shares change
-
-31.4M
-
Total reported value, excl. options
-
$73.5B
-
Value change
-
-$2.44B
-
Put/Call ratio
-
1.02
-
Number of buys
-
1061
-
Number of sells
-
-1149
-
Price
-
$74.31
Significant Holders of CVS HEALTH Corp - Common Stock (CVS) as of Q1 2023
2,550 filings reported holding CVS - CVS HEALTH Corp - Common Stock as of Q1 2023.
CVS HEALTH Corp - Common Stock (CVS) has 2,208 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 989M shares
of 1.27B outstanding shares and own 77.98% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (116M shares), BlackRock Inc. (93.5M shares), STATE STREET CORP (55M shares), Capital World Investors (32.6M shares), MORGAN STANLEY (31.3M shares), GEODE CAPITAL MANAGEMENT, LLC (23M shares), JPMORGAN CHASE & CO (22.5M shares), BANK OF AMERICA CORP /DE/ (17.9M shares), Invesco Ltd. (15.4M shares), and NORGES BANK (15M shares).
This table shows the top 2208 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.